Edwards Hunt Group
Edwards Hunt Group
  • Home
  • Services
  • About Us
  • Contact Us
  • Accomplishments
  • Clinical Trials
  • More
    • Home
    • Services
    • About Us
    • Contact Us
    • Accomplishments
    • Clinical Trials

  • Home
  • Services
  • About Us
  • Contact Us
  • Accomplishments
  • Clinical Trials

Accomplishments

Testimonials

Steven Young

Former Executive Director, Multiple Myeloma Research Consortium
Former President & Chief Operating Officer, Addario Lung Cancer Medical Institute

 

"Alicia is an extraordinary "get it done" leader and implementer within the clinical studies/biobanking fields, who is as comfortable developing strategy as she is driving tactics to efficiently and effectively deliver on goals. Over the past many years, I've heard nothing but compliments about Alicia and her staff from our business partners and collaborators. Whenever feasible, any company, foundation or organization I have the honor of helping to lead will seek to engage Alicia and Edwards-Hunt Group. Simply put, she's a dynamo and I trust her entirely to achieve desired results." 

  

Janet Freeman-Daily1, Lisa Goldman2, Tori Tomalia3, The ROS1ders4, Christine M. Lovely5, Manali I. Patel6, Alice T. Shaw7, Bonnie J. Addario8, Guneet Walia9, Steven W. Young9, Robert C. Doebele10
American Association for Cancer Research Annual Meeting 2018

"Special thanks to Alicia Sable-Hunt, RN, for helping to make the ALCMI PDX Study a reality, and for 24/7 staffing of the Cancer Model Project’s dedicated phone line." 

  


Kim Henderson

Senior Research Technologist at Mayo Clinic, Former Quality Assurance Manager of Tissue Bank at Multiple Myeloma Research Consortium 


"Alicia strived for excellence from each of the coordinators at contributing sites. She was able to do this by creating good working relationships, developing training manuals and was always available to help out. She was the troubleshooter being literally “on call” to answer any question and give advice for situations, errors and/or concerns. Alicia is a true professional. She always thought of the patient first and new the tissue bank was a valuable tool for pushing forward new drugs to an incurable and often overlooked cancer. She is hard working and innovative with her ideas. Alicia is truly a remarkable woman and I have no reservations recommending her.”

Recognition

 

  • Boca Magazine (2017) Business Profile – Alicia Sable-Hunt, RN, MBA, CCRA
  • Wilen-Daugenti, T., Vien, C.L., Molina-Ray, C. (2012) WOMEN LEAD Career Perspectives from Workplace Leaders. New York: Peter Lang.
  • Ettlinger, C. “Taking Care of Business: Taking a Bite Out of Cancer, Alicia Sable-Hunt.” scrubs magazine Summer 2012:26-27. Print.
  • Dowd-Higgins, C. (2011). This Is Not the Career I Ordered Empowering Strategies from Women Who Recharged, Reignited, and Reinvented Their Careers. Bloomington, IN: Reinvention Press.
  • Graham, K. (2010). Weight Loss EMPOWERMENT: Sable’s Foods – The Cancer Nutrition Challenge. 
  • FasterCure’s Who’s Who of Biobanking. 2005.
  • Freeman-Daily, J. (2018) The Global ROS1 Initiative: A patient-researcher partnership generating open-source, oncogene-driven cancer models and data                          

The Global ROS1 Initiative: a patient-researcher partnership generating open-source, oncogene-driven cancer models and data- Poster

Podcasts

Lynn Cancer Institute- Interview with Dr. Santos

Publications

  • Barbara J. Gitlitz, MD, Silvia Novello, MD, PhD, Tiziana Vavala, MD, Marisa Bittoni, PhD, Alicia Sable-Hunt, RN MBA, Dean Pavlick, BS, Robert Hsu, MD, S. Lani Park, PhD, MPH, Ruthia Chen, BA, Matthew Cooke, BA, Amy Moore, PhD, Alexa B. Schrock, PhD, Joan H. Schiller, MD, Bonnie J. Addario, Geoffrey R. Oxnard, MD.  The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer.  JTO Clinical And Research Reports July 01, 2021, Volume 2, Issue 7, 100194.
  • B. Gitlitz, S. L. Parks, M. Bittoni, A. Sable-Hunt, A. Moore, D. Pavlick, S. Novello, T. Vavala, R. Chen, G. Oxnard, Genetech, South San Francisco/ USA, Keck School of Medicine of USC, Los Angeles/ USA, Ohio State University, Columbus/ USA, GO2 Foundation for Lung Cancer, San Carlos/ USA, Addario Lung Cancer Medical Institute, Foundation Medicine, Cambridge/ USA, AOU San Luigi, University of Turin/ Italy, SC of Oncology Ospedale Civile di Saluzzo, ASL CN1, Saluzzo/ Italy, Dana-Farber Cancer Institute, Boston/ USA. P1.14 - Targeted Therapy. Posted Viewing in the Exhibit Hall, World Lung Poster, September 2019.
  • Barbara Gitlitz, Alicia Sable-Hunt, Steven Young, Andreas Kogelnik, Danielle Hicks, Deborah Morosini, Tiziana Vavala, Marisa Bittoni, S. Lani Park, Silvia Novello, Geoffrey Oxnard, Bonnie Addario.  P3.06-008 Employing Remote Web Consenting and Social Media to Facilitate Enrollment to an International Trial on Young Lung Cancer. Journal of Thoracic Oncology.  January 2017, volume 12, Issue 1, Supplement, Pages S1428-S1429.
  • Barbara J. Gitlitz, Deborah Morosini, Alicia L. Sable-Hunt, Bonnie J. Addario, Stacy L. Mach, Mark Byron Jennings, S. Lani Park, Marisa A Bittoni, Geoffrey R. Oxnard. The Genomics of Young Lung Cancer Study. ASCO Poster, 2016. 
  • Barbara J. Gitlitz, Deborah Morosini, Alicia L. Sable-Hunt, Bonnie J. Addario, Mark Byron Jennings, Stacy L. Mach, Geoffrey R. Oxnard. The genomics of Young Lung Cancer Study. 2015 American Society of Clinical Oncology, Annual Meeting May 29-June 2, 2015. J Clin Oncol 33, 2015 (suppl; abstr TPS11110)
  • Barbara J. Gitliz, Deborah Morosini, Alicia Sable-Hunt, Bonnie J Addario, Geoffrey R. Oxnard. The Genomics of Young Lung Cancer Study. American Associated for Cancer Research. Translation of the Cancer Genome, San Francisco, California, February 2015
  • Geoffrey R. Oxnard, Jennifer C. Heng, Elizabeth J. Root, Irene R. Rainville, Alicia L. Sable-Hunt, Kate P Shane-Carson, David Paul Carbone, Georgia L. Wiesner, Judy Ellen Garber. Initial results of a prospective, multicenter trial to study inherited lung cancer risk associated with germline EGFR T790M: INHERIT EGFR. ASCO Poster, 2015.
  • Gitlitz, B.J., Morosini, D., Sable-Hunt, A.L., Addario, B.J., Oxnard, G.R. The Genomics of Young Lung Cancer Study. ASCO Poster, 2015.
  • Oxnard, G.R., Heng, J., Rainville, I., Root, E., Dahlberg, S.E., Sable-Hunt, A.L., Wiesner, G.L., Taylor, K.A., Jackman, D.M., Janne, P.A., Garber, J.E. The INHERIT EGFR study: Investigating Hereditary Risk from T790M. AACR Poster, 2013.
  • Oxnard, G.R., Heng, J., Rainville, I., Root, E., Dahlberg, S.E., Sable-Hunt, A.L., Wiesner, G.L., Taylor, K.A., Jackman, D.M., Janne, P.A., Garber, J.E. The INHERIT EGFR study: Investigating Hereditary Risk from T790M. ASCO Poster, 2013.
  • Sable-Hunt, A. (2013). Clinical Trials. In Bonnie J. Addario Lung Cancer Foundation Navigating Lung Cancer 360 of Hope. San Carlos, CA. 
  • Sable-Hunt, A. (2010). Sable’s Foods – The Cancer Nutrition Challenge. In Weight Loss EMPOWERMENT (pp. 231, 232). Rancho Santa Margarita, CA: Grande Gringos, Inc.
  • Ahmann, G., Chng, WJ., Henderson, K., Price-Troska, TL., DeGoey, RW., Timm, MM., Dispenzieri, A., Greipp, PR., Sable-Hunt, A., Bergsagel, L., Fonseca, R. Impact of Tissue Shipping on Plasma Cell Isolation, Viability, and RNA Integrity in the Context of a Centralized Good Laboratory Practice Certified Tissue Banking Facility. AACR 2008. 
  • Stewart, AK, Chang, H., Trudel, S., Anderson, KC, Richardson, P., Alsina, M., Reece, D., Young, S., Sable-Hunt, A., Li, Z., Keats, J., Van Wier, S., Ahmann, G., Price-Troska, T., Giusti, K., Bergsagel, PL, Chesi, M., Fonseca, R. (2007). Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution. Leukemia, 21(11): 10.1038. NIHMSID: NIHMS181755. PMCID: PMC3882151
  • Stewart, K., Tudel, S., Chang, H., Anderson, K., Richardson, P., Alsina, M., Reece, D.E., Greipp, P., Young, S., Sable-Hunt, A., Li, Z.H., Keats, J., Van Wier, S., Ahmann, G., Price-Troska, T., Giusti, K., Fonseca, R. Diagnostic Evaluation of t[4;14] in Multiple Myeloma. ASH Poster, December 2006. 
  • Sable-Hunt, A. (2006). Case study: Multiple Myeloma Research Consortium. LabVantage Solutions.
  • R. C. Frank, A. Coscia, L. Versea, N. Cohen, R. Zelkowitz, A. Ruskin, A. Skeris (Sable-Hunt), P. Dodds and K. Nair. Low dose docetaxel, estramustine and thalidomide followed by maintenance thalidomide for the treatment of hormone refractory prostate cancer (HRPC): A phase II community based trial.  J Clin Oncol (Meeting Abstracts) July 2004 vol. 22 no. 14_suppl 4681.

CCRA Certification

ACRP-PM Certification

Copyright © 2021 Edwards Hunt Group - All Rights Reserved.

Powered by GoDaddy